Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 169

1.
3.

In multiple myeloma, clonotypic B lymphocytes are detectable among CD19+ peripheral blood cells expressing CD38, CD56, and monotypic Ig light chain.

Bergsagel PL, Smith AM, Szczepek A, Mant MJ, Belch AR, Pilarski LM.

Blood. 1995 Jan 15;85(2):436-47. Erratum in: Blood 1995 Jun 1;85(11):3365.

4.
5.
6.

Leukemic B cells clonally identical to myeloma plasma cells are myelomagenic in NOD/SCID mice.

Pilarski LM, Seeberger K, Coupland RW, Eshpeter A, Keats JJ, Taylor BJ, Belch AR.

Exp Hematol. 2002 Mar;30(3):221-8.

PMID:
11882359
7.

Multiple myeloma: new evidence and insights from the immunoglobulin heavy chain gene and phenotypes.

Takishita M, Kosaka M.

Leuk Lymphoma. 1995 Nov;19(5-6):395-400. Review.

PMID:
8590838
8.

Cellular origin and extent of clonal involvement in multiple myeloma: genetic and phenotypic studies.

Takishita M, Kosaka M, Goto T, Saito S.

Br J Haematol. 1994 Aug;87(4):735-42.

PMID:
7986715
9.

Flow cytometric disease monitoring in multiple myeloma: the relationship between normal and neoplastic plasma cells predicts outcome after transplantation.

Rawstron AC, Davies FE, DasGupta R, Ashcroft AJ, Patmore R, Drayson MT, Owen RG, Jack AS, Child JA, Morgan GJ.

Blood. 2002 Nov 1;100(9):3095-100.

10.

Phenotyping studies of clonotypic B lymphocytes from patients with multiple myeloma by flow cytometry.

Conway EJ, Wen J, Feng Y, Mo A, Huang WT, Keever-Taylor CA, Hari P, Vesole DH, Chang CC.

Arch Pathol Lab Med. 2009 Oct;133(10):1594-9. doi: 10.1043/1543-2165-133.10.1594.

PMID:
19792049
11.

B-lymphocyte suppression in multiple myeloma is a reversible phenomenon specific to normal B-cell progenitors and plasma cell precursors.

Rawstron AC, Davies FE, Owen RG, English A, Pratt G, Child JA, Jack AS, Morgan GJ.

Br J Haematol. 1998 Jan;100(1):176-83.

PMID:
9450807
12.
13.

Circulating plasma cells in multiple myeloma: characterization and correlation with disease stage.

Rawstron AC, Owen RG, Davies FE, Johnson RJ, Jones RA, Richards SJ, Evans PA, Child JA, Smith GM, Jack AS, Morgan GJ.

Br J Haematol. 1997 Apr;97(1):46-55.

PMID:
9136941
14.

Circulating clonal lymphocytes in myeloma determined by mRNA in situ hybridization.

Joshua DE, Brown RD, Luo XF, Gibson J.

Blood. 1996 Aug 1;88(3):1125. No abstract available.

17.

Circulating clonotypic B cells in multiple myeloma and monoclonal gammopathy of undetermined significance.

Thiago LS, Perez-Andres M, Balanzategui A, Sarasquete ME, Paiva B, Jara-Acevedo M, Barcena P, Sanchez ML, Almeida J, González M, San Miguel JF, Garcia-Sanz R, Orfao A.

Haematologica. 2014 Jan;99(1):155-62. doi: 10.3324/haematol.2013.092817. Epub 2013 Jul 19.

19.

Myeloma VL and VH gene sequences reveal a complementary imprint of antigen selection in tumor cells.

Sahota SS, Leo R, Hamblin TJ, Stevenson FK.

Blood. 1997 Jan 1;89(1):219-26.

20.

Clonally related IgA- and IgE-secreting plasma cells in a myeloma patient.

Bakkus MH, Schots R, Gomez La Fuente PB, Van Riet I, Thielemans K, De Waele M, Van Camp B.

Eur J Haematol. 2000 Nov;65(5):348-55.

PMID:
11092467

Supplemental Content

Support Center